Bookbot

W. F. Boyer

    Perspectives in Psychiatry - 1: Selective Serotonin Re-Uptake Inhibitors
    Perspectives in Psychiatry - 2: Diagnosis of Depression
    Selective Serotonin Re-Uptake Inhibitors
    • Selective Serotonin Re-Uptake Inhibitors

      Second Edition. Advances in Basic Research and Clinical Practice

      Interest in Selective Serotonin Re-Uptake Inhibitors has grown considerably in recent years, particularly as their therapeutic profile is expanding to the treatment of other types of psychiatric disorder besides depression. It is therefore timely that the authors of Selective Serotonin Re-Uptake Inhibitors should now provide a second edition. Reorganised and updated to include additional chapters which greatly extend the scope of the book, this edition gives an excellent review of the biochemical, pharmacological and clinical aspects of this important group of drugs. Written by an array of outstanding, authoritative, international scientists and clinicians this invaluable reference provides a wealth of knowledge and an extensive source of up-to-date references on a subject that is important to every clinician involved in treating psychiatric patients as well as those carrying out research in this field.

      Selective Serotonin Re-Uptake Inhibitors
    • Perspectives in Psychiatry Volume 2 Diagnosis of Depression J.P. Feighner and W.F. Boyer Feighner Research Institute, San Diego, California, USA Depression is common, multifaceted and treatable. This book brings together a wide variety of views, methods and disciplines in the modern, symptom-orientated diagnosis of depression. Beginning with a historical overview and an epidemiological survey of depression, it includes important summaries of the rationale behind classifications such as ICD-10 and DSM-IV. It also reviews key areas such as masked depression, biological markers, recurrent brief depression and chronic resistant depression. This book focuses on a comprehensive and systematic global approach to the diagnosis of depression and will be of value to all psychiatrists and physicians with clinical or research interests in this subject. Perspectives in Psychiatry Series O. Benkert (Germany) J.P. Feighner (USA) J.J. López-Ibor (Spain) S.A. Montgomery (UK) G.B. Cassano (Italy) D.G. Grahame-Smith (UK) J. Mendlewicz (Belgium) F. Rouillon (France) Volume 1: Selective Serotonin Re-uptake Inhibitors Edited by J.P. Feighner and W.F. Boyer ISBN 0 471 92890 9 1991 168 pp Volume 3: Long-term Treatment of Depression Edited by S.A. Montgomery and F. Rouillon ISBN 0 471 92892 5 due December 1991 approx 250 pp

      Perspectives in Psychiatry - 2: Diagnosis of Depression
    • Perspectives in Psychiatry - 1: Selective Serotonin Re-Uptake Inhibitors

      The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline

      • 168 stránok
      • 6 hodin čítania

      With a minimum of side effects, low toxicity in overdose and a broad range of clinical applications, selective serotonin re-uptake inhibitors have found widespread and increasing use in psychiatry worldwide. Here is the most comprehensive reference source available on these important drugs. Beginning with examinations of the drugs' pharmacology their effects on serotonergic function and the central role of serotonin in many psychiatric disorders, the book moves on to reviews of clinical trials in many psychiatric conditions. Finally, an important chapter discusses clinical issues in the use of these agents.

      Perspectives in Psychiatry - 1: Selective Serotonin Re-Uptake Inhibitors